The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 19, 2024
Filed:
Dec. 12, 2018
Curevac SE, Tübingen, DE;
Sanofi Pasteur, Lyons, FR;
Patrick Baumhof, Tübingen, DE;
Wolfgang Grosse, Tübingen, DE;
Edith Jasny, Tübingen, DE;
Thomas Kramps, Tübingen, DE;
Daniel Voss, Tübingen, DE;
Julia Dannenmaier, Tübingen, DE;
Valérie Lecouturier, Chazay d'Azergues, FR;
Yves Girerd-Chambaz, Messimy, FR;
CureVac SE, Tübingen, DE;
Sanofi Pasteur, Lyons, FR;
Abstract
The present invention is directed to an artificial nucleic acid and to a polypeptide suitable for use in the treatment or prophylaxis of an infection with a flavivirus, in particular an infection with yellow fever virus or with dengue virus, or of a disorder related to such an infection. The present invention is also directed to a composition, preferably an immunogenic composition, comprising the artificial nucleic acid or the inventive polypeptide. In particular, the present invention concerns an immunogenic composition against a flavivirus, such as yellow fever virus or dengue virus. Further, the invention concerns a kit, particularly a kit of parts, comprising the artificial nucleic acid, polypeptide or (immunogenic) composition. The invention is further directed to a method of treating or preventing a disorder or a disease, first and second medical uses of the artificial nucleic acid, polypeptide, composition, in particular the first and second medical uses of the immunogenic composition according to the invention.